Home LiteratureArticle Details
PMID: 21525412 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Acetylation of lysine 120 of p53 endows DNA-binding specificity at effective physiological salt concentration.

Arbely E, Natan E, Brandt T, Allen MD, Veprintsev DB, Robinson CV, Chin JW, Joerger AC, Fersht AR

Abstract

Lys120 in the DNA-binding domain (DBD) of p53 becomes acetylated in response to DNA damage. But, the role and effects of acetylation are obscure. We prepared p53 specifically acetylated at Lys120, AcK120p53, by in vivo incorporation of acetylated lysine to study biophysical and structural consequences of acetylation that may shed light on its biological role. Acetylation had no affect on the overall crystal structure of the DBD at 1.9-Å resolution, but significantly altered the effects of salt concentration on specificity of DNA binding. p53 binds DNA randomly in vitro at effective physiological salt concentration and does not bind specifically to DNA or distinguish among its different response elements until higher salt concentrations. But, on acetylation, AcK120p53 exhibited specific DNA binding and discriminated among response elements at effective physiological salt concentration. AcK120p53 and p53 had the highest affinity to the same DNA sequence, although acetylation reduced the importance of the consensus C and G at positions 4 and 7, respectively. Mass spectrometry of p53 and AcK120p53 DBDs bound to DNA showed they preferentially segregated into complexes that were either DNA(p53DBD)(4) or DNA(AcK120DBD)(4), indicating that the different DBDs prefer different quaternary structures. These results are consistent with electron microscopy observations that p53 binds to nonspecific DNA in different, relaxed, quaternary states from those bound to specific sequences. Evidence is accumulating that p53 can be sequestered by random DNA, and target search requires acetylation of Lys120 and/or interaction with other factors to impose specificity of binding via modulating changes in quaternary structure.

MeSH Terms
Acetylation Binding Sites Crystallography, X-Ray DNA/metabolism DNA Damage Escherichia coli Lysine/chemistry Lysine-tRNA Ligase/metabolism Methanosarcina barkeri/chemistry,metabolism Models, Molecular Protein Engineering Protein Structure, Tertiary Salts/chemistry Tumor Suppressor Protein p53/chemistry
Chemicals
Salts Tumor Suppressor Protein p53 DNA Lysine-tRNA Ligase Lysine
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Arbely Eyal
Medical Research Council Laboratory of Molecular Biology, Hills Road, Cambridge CB2 0QH, United Kingdom.
Natan Eviatar
Brandt Tobias
Allen Mark D
Veprintsev Dmitry B
Robinson Carol V
Chin Jason W
Joerger Andreas C
Fersht Alan R
References (47)
47 references, click to expand
  1. The CCP4 suite: programs for protein crystallography.
    Acta Crystallogr D Biol Crystallogr. 1994 Sep 1;50(Pt 5):760-3 PMID: 15299374
  2. Genetically encoding N(epsilon)-acetyllysine in recombinant proteins.
    Nat Chem Biol. 2008 Apr;4(4):232-4 PMID: 18278036
  3. MolProbity: all-atom contacts and structure validation for proteins and nucleic acids.
    Nucleic Acids Res. 2007 Jul;35(Web Server issue):W375-83 PMID: 17452350
  4. A single-molecule characterization of p53 search on DNA.
    Proc Natl Acad Sci U S A. 2011 Jan 11;108(2):563-8 PMID: 21178072
  5. Features and development of Coot.
    Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501 PMID: 20383002
  6. Interpretation of monovalent and divalent cation effects on the lac repressor-operator interaction.
    Biochemistry. 1977 Nov 1;16(22):4791-6 PMID: 911790
  7. Physiological buffers for NMR spectroscopy.
    J Biomol NMR. 1995 Apr;5(3):321-2 PMID: 22911504
  8. Semirational design of active tumor suppressor p53 DNA binding domain with enhanced stability.
    Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):14675-80 PMID: 9843948
  9. Cooperative binding of tetrameric p53 to DNA.
    J Mol Biol. 2004 Aug 27;341(5):1145-59 PMID: 15321712
  10. Scaling and assessment of data quality.
    Acta Crystallogr D Biol Crystallogr. 2006 Jan;62(Pt 1):72-82 PMID: 16369096
  11. Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest and apoptosis.
    Mol Cell. 2006 Dec 28;24(6):827-39 PMID: 17189186
  12. The C-terminal lysines fine-tune P53 stress responses in a mouse model but are not required for stability control or transactivation.
    Proc Natl Acad Sci U S A. 2005 Jul 19;102(29):10188-93 PMID: 16006521
  13. The role of mass spectrometry in structure elucidation of dynamic protein complexes.
    Annu Rev Biochem. 2007;76:167-93 PMID: 17328674
  14. Determining the stoichiometry and interactions of macromolecular assemblies from mass spectrometry.
    Nat Protoc. 2007;2(3):715-26 PMID: 17406634
  15. Measurement of cytosolic free magnesium ion concentration by 19F NMR.
    Biochemistry. 1988 May 31;27(11):4041-8 PMID: 3415971
  16. Transcriptional control of human p53-regulated genes.
    Nat Rev Mol Cell Biol. 2008 May;9(5):402-12 PMID: 18431400
  17. Blinded by the Light: The Growing Complexity of p53.
    Cell. 2009 May 1;137(3):413-31 PMID: 19410540
  18. Electron microscopy studies on the quaternary structure of p53 reveal different binding modes for p53 tetramers in complex with DNA.
    Proc Natl Acad Sci U S A. 2011 Jan 11;108(2):557-62 PMID: 21178074
  19. Structural basis of DNA recognition by p53 tetramers.
    Mol Cell. 2006 Jun 23;22(6):741-753 PMID: 16793544
  20. Acetylation is indispensable for p53 activation.
    Cell. 2008 May 16;133(4):612-26 PMID: 18485870
  21. Crystal structure of a superstable mutant of human p53 core domain. Insights into the mechanism of rescuing oncogenic mutations.
    J Biol Chem. 2004 Jan 9;279(2):1291-6 PMID: 14534297
  22. Single-Molecule characterization of oligomerization kinetics and equilibria of the tumor suppressor p53.
    Nucleic Acids Res. 2011 Mar;39(6):2294-303 PMID: 21097469
  23. Electrospray ionization for mass spectrometry of large biomolecules.
    Science. 1989 Oct 6;246(4926):64-71 PMID: 2675315
  24. Crystal structure of the p53 core domain bound to a full consensus site as a self-assembled tetramer.
    Structure. 2010 Feb 10;18(2):246-56 PMID: 20159469
  25. Structure of the human p53 core domain in the absence of DNA.
    Acta Crystallogr D Biol Crystallogr. 2007 Mar;63(Pt 3):276-81 PMID: 17327663
  26. Quantitative evaluation of noncovalent chorismate mutase-inhibitor binding by ESI-MS.
    J Am Soc Mass Spectrom. 2003 Dec;14(12):1470-6 PMID: 14652193
  27. Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations.
    Science. 1994 Jul 15;265(5170):346-55 PMID: 8023157
  28. Functional analysis of the roles of posttranslational modifications at the p53 C terminus in regulating p53 stability and activity.
    Mol Cell Biol. 2005 Jul;25(13):5389-95 PMID: 15964796
  29. Cytosolic free magnesium concentration in cultured chick heart cells.
    Am J Physiol. 1989 Jul;257(1 Pt 1):C141-6 PMID: 2750886
  30. Nonspecific DNA binding of genome-regulating proteins as a biological control mechanism: measurement of DNA-bound Escherichia coli lac repressor in vivo.
    Proc Natl Acad Sci U S A. 1977 Oct;74(10):4228-32 PMID: 412185
  31. Comparative binding of p53 to its promoter and DNA recognition elements.
    J Mol Biol. 2005 May 6;348(3):589-96 PMID: 15826656
  32. PHENIX: building new software for automated crystallographic structure determination.
    Acta Crystallogr D Biol Crystallogr. 2002 Nov;58(Pt 11):1948-54 PMID: 12393927
  33. Acetylation of the DNA binding domain regulates transcription-independent apoptosis by p53.
    J Biol Chem. 2009 Jul 24;284(30):20197-205 PMID: 19494119
  34. Structures of p53 cancer mutants and mechanism of rescue by second-site suppressor mutations.
    J Biol Chem. 2005 Apr 22;280(16):16030-7 PMID: 15703170
  35. Solving structures of protein complexes by molecular replacement with Phaser.
    Acta Crystallogr D Biol Crystallogr. 2007 Jan;63(Pt 1):32-41 PMID: 17164524
  36. Sequence logos: a new way to display consensus sequences.
    Nucleic Acids Res. 1990 Oct 25;18(20):6097-100 PMID: 2172928
  37. Conservation of DNA-binding specificity and oligomerisation properties within the p53 family.
    BMC Genomics. 2009 Dec 23;10:628 PMID: 20030809
  38. Protein subunit interactions and structural integrity of amyloidogenic transthyretins: evidence from electrospray mass spectrometry.
    J Mol Biol. 1998 Aug 21;281(3):553-64 PMID: 9698569
  39. Acetylation of the p53 DNA-binding domain regulates apoptosis induction.
    Mol Cell. 2006 Dec 28;24(6):841-51 PMID: 17189187
  40. Mutational analysis of the p53 core domain L1 loop.
    J Biol Chem. 2006 Jul 21;281(29):20464-73 PMID: 16687402
  41. Thermodynamic stability of wild-type and mutant p53 core domain.
    Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14338-42 PMID: 9405613
  42. The expanding universe of p53 targets.
    Nat Rev Cancer. 2009 Oct;9(10):724-37 PMID: 19776742
  43. Algorithm for prediction of tumour suppressor p53 affinity for binding sites in DNA.
    Nucleic Acids Res. 2008 Mar;36(5):1589-98 PMID: 18234719
  44. Non-specific DNA binding of genome regulating proteins as a biological control mechanism: I. The lac operon: equilibrium aspects.
    Proc Natl Acad Sci U S A. 1974 Dec;71(12):4808-12 PMID: 4612528
  45. Modes of p53 regulation.
    Cell. 2009 May 15;137(4):609-22 PMID: 19450511
  46. Structural biology of the tumor suppressor p53.
    Annu Rev Biochem. 2008;77:557-82 PMID: 18410249
  47. Regulating the p53 pathway: in vitro hypotheses, in vivo veritas.
    Nat Rev Cancer. 2006 Dec;6(12):909-23 PMID: 17128209
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
1091-6490
Published
2011-05-17
Epub
2011-00-27
Pages
8251-6
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC3100949
Subset
IM
Grants
Medical Research Council · MC_U105181009 · United Kingdom
Medical Research Council · MC_UP_A024_1008 · United Kingdom
Medical Research Council · MC_UP_A024_1010 · United Kingdom
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]